GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
GlaxoSmithKline (GSK) has announced promising data for its Zejula (niraparib) drug as a maintenance therapy in the Phase III PRIMA...
Trending menu:
-
![Trials data suggests Cosentyx from Novartis will change psoriasis market]()
Trials data suggests Cosentyx from Novartis will change psoriasis market
-
![Eligibility criteria for clinical trials report challenges in representing LN patients]()
Eligibility criteria for clinical trials report challenges in representing LN patients
-
![Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities]()
Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities
-
![Longboat Clinical launches Patient CONNECT to ease patient recruitment process]()
Longboat Clinical launches Patient CONNECT to ease patient recruitment process
-
![Parexel launches integrated FPS model to drive delivery of clinical research partnerships]()
Parexel launches integrated FPS model to drive delivery of clinical research partnerships
-
![Fragmented processes slow down clinical trials, finds survey]()
Fragmented processes slow down clinical trials, finds survey
Expert commentary & analysis from GlobalData
Aurinia still has potential Phase III lupus nephritis mortality risk
Zolgensma and Spinraza may face spinal muscular atrophy market shortfall
Clinical trials landscape for type 2 diabetes analysed
Ulcerative colitis clinical trials analysed over the last five years
Most Read
Company releases
Pharmaceutical Drug Development and Particle Sizing
Typically, when an individual is suffering from minor ailments at home, such as a headache, heartburn or a common cold,...
Sometimes, You Have to Move to Go Forward
Inocure at Electrospin, China
Inocure presented at the 6th International Conference on Electrospinning in China.
See Malvern Panalytical’s Upcoming Webinars
Pfanstiehl to Attend Two Events in August
Pfanstiehl has announced that it will be sponsoring the 2019 Colorado Protein Stability Conference.
Company whitepapers
Study: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12
Primary Cells Isolated from Healthy Human and Animal Tissues
STZ-Induced Rat Model of Diabetes
Noble Life SciencesUnderstanding Sucrose: Matching Sucrose Quality to Functional Need
PfanstiehlClinical Trials: Gene Therapy
GlobalDataClinical Trials: A Round-Up of 2018
GlobalDataProtein Sciences Platform
Company A-Z
Clinical Trials
Redx Pharma to continue studying RXC004 in Phase I/II trial
UK-based biotechnology firm Redx Pharma has received a recommendation from a safety review committee to continue the evaluation of its cancer asset, RXC004, in an...
Study finds majority of cancer drug trials lack racial diversity
Mallinckrodt’s terlipressin shows positive profile in CONFIRM study
Lynparza improves survival in Phase III ovarian cancer patients
Lilly’s Taltz meets Phase IV plaque psoriasis trial endpoints
Drug Development
Lynparza improves survival in Phase III ovarian cancer patients
AstraZeneca and MSD have reported that the Phase III PAOLA-1 study of Lynparza (olaparib) in combination with bevacizumab met the primary endpoint in advanced ovarian...
AstraZeneca reports positive results from trial of Tagrisso
AAV gene therapy shows positive results in Batten disease trial
Lilly reports improved survival in Verzenio’s MONARCH 2 trial
Alkermes-Biogen’s MS drug shows improved GI tolerability
Identify the key trends in the immuno-oncology market over the next two years
Go Top